Cochlear Ltd
ASX:COH

Watchlist Manager
Cochlear Ltd Logo
Cochlear Ltd
ASX:COH
Watchlist
Price: 260.19 AUD -0.13% Market Closed
Market Cap: 17B AUD

Cochlear Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cochlear Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cochlear Ltd
ASX:COH
Cash from Operating Activities
AU$237.6m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
2%
Somnomed Ltd
ASX:SOM
Cash from Operating Activities
AU$7.8m
CAGR 3-Years
61%
CAGR 5-Years
8%
CAGR 10-Years
N/A
C
Cyclopharm Ltd
ASX:CYC
Cash from Operating Activities
-AU$13.7m
CAGR 3-Years
-90%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Optiscan Imaging Ltd
ASX:OIL
Cash from Operating Activities
-AU$6.2m
CAGR 3-Years
-17%
CAGR 5-Years
-35%
CAGR 10-Years
-16%
Austco Healthcare Ltd
ASX:AHC
Cash from Operating Activities
AU$13.4m
CAGR 3-Years
90%
CAGR 5-Years
32%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Cash from Operating Activities
-AU$7.8m
CAGR 3-Years
-27%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
No Stocks Found

Cochlear Ltd
Glance View

Cochlear Ltd., the renowned medical device company, traces its roots back to the vibrant medical innovation scene of Australia in the 1980s. Born from the pioneering research of Professor Graeme Clark, who was driven by a personal mission to help the hearing-impaired, Cochlear embarked on a journey that redefined the possibilities for those living with hearing loss. Over the years, the company has evolved into a global leader in implantable hearing solutions, headlined by its flagship cochlear implants. These intricate devices bypass damaged portions of the ear, directly stimulating the auditory nerve to restore the sense of hearing, thus providing users with the ability to connect more profoundly with the world around them. As scientific research advanced, so did Cochlear, developing a range of complementary products tailored to different degrees and types of hearing impairment. In a business model built on innovation and patient support, Cochlear generates revenue by designing, manufacturing, and marketing a portfolio of hearing implant products and related services. The company's value proposition lies not only in the initial sale of these high-tech devices but also in the ongoing customer relationships through upgrades, accessories, and maintenance services. By investing significantly in research and development, Cochlear ensures continuous improvement and the introduction of new solutions that meet the evolving needs of patients and healthcare providers. Their ability to offer comprehensive post-implantation support, such as rehabilitation services and patient care programs, strengthens customer loyalty and establishes recurring revenue streams, enabling Cochlear to maintain its competitive edge in the global market.

COH Intrinsic Value
228.14 AUD
Overvaluation 12%
Intrinsic Value
Price

See Also

What is Cochlear Ltd's Cash from Operating Activities?
Cash from Operating Activities
237.6m AUD

Based on the financial report for Jun 30, 2025, Cochlear Ltd's Cash from Operating Activities amounts to 237.6m AUD.

What is Cochlear Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
2%

Over the last year, the Cash from Operating Activities growth was -39%. The average annual Cash from Operating Activities growth rates for Cochlear Ltd have been -14% over the past three years , and 2% over the past ten years .

Back to Top